Product logins

Find logins to all Clarivate products below.


: Generics

Here you will find relevant articles and insight into all Clarivate related products and news.

After loss of exclusivity, small-molecule generics bite quick and hard, while biologics remain resilient After loss of exclusivity, small-molecule generics bite quick and hard, while biologics remain resilient
Blog August 28, 2024
After loss of exclusivity, small-molecule generics bite quick and hard, while biologics remain resilient
Generics IP lifecycle management Market Access
The role of artificial intelligence or machine learning in conducting systematic literature reviews now and in future The role of artificial intelligence or machine learning in conducting systematic literature reviews now and in future
Blog June 21, 2024
The role of artificial intelligence or machine learning in conducting systematic literature reviews now and in future
Clinical research Clinical trials corporate
Tenofovir alafenamide fumarate raises targeting questions Tenofovir alafenamide fumarate raises targeting questions
Blog October 17, 2019
Tenofovir alafenamide fumarate raises targeting questions
Generics
Boost in Paragraph Four patent challenges drives competitive generics marketplace Boost in Paragraph Four patent challenges drives competitive generics marketplace
Blog March 28, 2019
Boost in Paragraph Four patent challenges drives competitive generics marketplace
Generics Regulatory intelligence
How regulation, innovation, quality and access are inevitably intertwined How regulation, innovation, quality and access are inevitably intertwined
Blog November 13, 2018
How regulation, innovation, quality and access are inevitably intertwined
Generics Regulatory Research and development
Blog February 6, 2018
Modern tools to advance generic drug development and review
Generics Research and development
Blog November 16, 2017
For the tradition-bound biopharma industry, resisting change is no longer an option
Biopharma Cortellis Generics
Blog August 8, 2017
Second Remicade biosimilar offers glimpse of competitive U.S. market in the future
Generics Market Access

Generics

온디맨드 웨비나 사이트런칭 온디맨드 웨비나 사이트런칭
Blog March 15, 2022
온디맨드 웨비나 사이트런칭
After loss of exclusivity, small-molecule generics bite quick and hard, while biologics remain resilient After loss of exclusivity, small-molecule generics bite quick and hard, while biologics remain resilient
Blog August 28, 2024
After loss of exclusivity, small-molecule generics bite quick and hard, while biologics remain resilient
The role of artificial intelligence or machine learning in conducting systematic literature reviews now and in future The role of artificial intelligence or machine learning in conducting systematic literature reviews now and in future
Blog June 21, 2024
The role of artificial intelligence or machine learning in conducting systematic literature reviews now and in future
Tenofovir alafenamide fumarate raises targeting questions Tenofovir alafenamide fumarate raises targeting questions
Blog October 17, 2019
Tenofovir alafenamide fumarate raises targeting questions
Boost in Paragraph Four patent challenges drives competitive generics marketplace Boost in Paragraph Four patent challenges drives competitive generics marketplace
Blog March 28, 2019
Boost in Paragraph Four patent challenges drives competitive generics marketplace
How regulation, innovation, quality and access are inevitably intertwined How regulation, innovation, quality and access are inevitably intertwined
Blog November 13, 2018
How regulation, innovation, quality and access are inevitably intertwined
Blog February 6, 2018
Modern tools to advance generic drug development and review
Blog November 16, 2017
For the tradition-bound biopharma industry, resisting change is no longer an option
Blog August 8, 2017
Second Remicade biosimilar offers glimpse of competitive U.S. market in the future
Blog May 31, 2017
Positive outlook for CDMOs at CPhI North America, but companies need to be ready for challenges
Blog May 25, 2017
DCAT Week ’17 session looks at emerging pharma market trends